Sponsored Symposia

We thank our sponsors for their support of Blood ISBT 2025. 

Below is the schedule for our Sponsored Symposia. These sessions are free to attend, but space is limited. To register, please email blood@theconferencecompany.com.

Time: 12:15 PM - 1:15 PM (catering available in the Bellevue Foyer from 12:15)

Speakers:
Ramune Sepetiene, Director Medical & Scientific Affairs, Abbott

Location: 
Bellevue 1, PCEC

Time: 12:15 PM - 1:15PM (catering available in the Bellevue Foyer from 12:15)

Speakers:
Ariane Caesar, Medion Diagnostics Grifols AG, Switzerland
Annette Le Viellez, Fiona Stanley Hospital, Australia

Chairperson:
Xiaomei Zhu, Grifols, APAC, Singapore

Location: 
Bellevue 2, PCEC

Synopsis:
The use of monoclonal anti-CD38 (daratumumab and isatuximab) in treating multiple myeloma is a longstanding therapy that is expected to grow among this patient population. Presently, anti-CD38 therapy for light chain amyloidosis, anti-PLA2R antibody-positive membranous nephropathy, or other autoimmune mediated diseases are either under, or considered for investigation, indicating a continued expansion with its use and potentially growing number of patients receiving anti-CD38 therapy in the near future. To address the interference anti-CD38 has in pre-transfusion antibody screening and identification testing, Grifols has introduced a soluble form of CD38 (sCD38) for use in a rapid method to mitigate the interference by anti-CD38.

In this symposium, join us to hear the latest findings from two clinical studies and a transfusion laboratory setting based on patient sample testing.

These presentations will highlight the effectiveness of sCD38 in mitigating anti-CD38 interference and its value as a powerful tool for enhancing blood typing efficiency.

Time: 7:30 PM - till late

Speakers:
Sattva Neelapu, The University of Texas M.D. Anderson Cancer Center
Laurie Sehn, The University of British Columbia

Chairperson:
Duncan Purtill

Location: 
The Ritz Carlton, 1 Barrack St, Perth WA 6000, Australia

Time: 7:30 PM - 9:30 PM

Speakers:
Ghassan Zammar, Sir Charles Gairdner Hospital
Matthew Davids, Dana-Farber Cancer Institute 
Chan Cheah, Sir Charles Gairdner Hospital
Kat Lewis, Sir Charles Gairdner Hospital 

Chairperson:
Chan Cheah, Sir Charles Gairdner Hospital

Location:
 Meeting Room 8, PCEC

Synopsis:
Session 1: Managing CLL in Practice: From Case to Conversation 
Session 2: Managing CLL Across Continents: Fireside Perspectives From the US and Australia
Session 3: From Case to Consensus: Practical Management of DLBCL 
Session 4: Advancing DLBCL Care: Insights and Implications for Australian Practice 

Time: 7:15 AM - 8:15 AM (breakfast available from 7:00 AM)

Speakers:
John Seymour, Peter Maccullum Cancer Centre

Chairperson:
Chan Cheah, Sir Charles Gairdner Hospital

Location:
Riverview 4, PCEC

Please come prepared to discuss practical approaches and immediate actions you can take for your first-line CLL patients, using relevant cases or examples from your own experience.

Time: 7:00 AM - 7:45 AM (breakfast available from 6:30 AM)

Speakers:
Gordon Cook, University of Leeds
Tom Martin, UCSF Medical Center

Chairperson:
Andrew Spencer, Alfred Health, Australia

Location:
Riverview 5, PCEC

Time: 12:15 PM - 1:15 PM (catering available in the Bellevue Foyer from 12:15)

Speaker:
José Eduardo Levi, Grifols, Sao Paulo, Brazil

Chairperson:
Xiaomei Zhu, Grifols, APAC, Singapore

Location:
Bellevue 2, PCEC

Synopsis:
This symposium will focus on arboviruses, increasingly recognized as emerging and re-emerging pathogens with significant implications for transfusion-transmitted infections. Join us for an in-depth exploration of:
• Most current data on the epidemiology of key arboviruses, their natural histories, and their impact on blood safety worldwide
• Gain insights into documented cases of transfusion transmission, regional prevalence trends, and the evolving strategies used to safeguard blood supplies
• Learn ongoing surveillance efforts and innovative mitigation approaches, equipping participants with the latest knowledge to inform policy and practice in transfusion medicine

Time: 12:15 PM - 1:15 PM (catering available in the Bellevue Foyer from 12:15)

Speakers:
Rasika Dhawan Setia, BLK-MAX Super Speciality Hospital
Mark Howard, Head of Department Pathlab, Werfen
Sandrine Corbier
Ramona Chopra

Location:
Bellevue 1, PCEC

Synopsis:
Session 1: A Step-Up in Immunohematology: Occult Antibody Detection and Monoclonal Antibody Screening, Powered by SPRCA
Session 2: Smarter Platelet Matching: How Capture P Crossmatch Improves Transfusion Outcomes
Session 3: Simplify transfusion workflows with ImmuLink

Time: 7:00 PM - 9:00 PM

Speakers:
Zi Yun Ng, Royal Perth Hospital
Andrew Perkins, Alfred Health, The Australian Centre For Blood Diseases, Monash University
David Ross, SA Pathology

Location:
The Mark, Como The Treasury, 1 Cathedral Avenue, Perth WA 6000, Australia

Time: 7:15 AM - 8:15 AM (breakfast available from 7:00 AM)

Speakers:
Aaron Sverdlov, University of Newcastle and Hunter New England Health
Monique Menzies Wojtowicz, Macquarie University and Northern Beaches Hospitals

Time: 7:15 AM - 8:15 AM (breakfast available from 7:00 AM)

Speaker:
Mohamad Mohty, Sorbonne University

Panelists:
Phoebe Joy Ho, Royal Prince Alfred Hospital
Cindy Lee, Royal Adelaide Hospital
Wojciech Janowski, Calvary Mater Newcastle

Chairperson:
Hang Quach, St Vincent’s Hospital

Time: 12:15 PM - 1:15 PM (catering available in the Bellevue Foyer from 12:15)

Speakers:
Martin Olsson, Nordic Reference Laboratory For Blood Group Genomics

Time:  12:15 PM - 1:15 PM (catering available in the Bellevue Foyer from 12:15)

Speaker:
Ajay Gandhi, Werfen

Synopsis:
Session 1: 20 minutes Topic: Leveraging Laboratory Coagulation Diagnostics for Optimizing Transfusions Followed by Q&A - 5 minutes
Session 2: 20 minutes Topic: Goal-directed bleeding management using point of care diagnostics: Updates on evidence and recommendations Followed by Q&A - 5 Minutes